Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
<p dir="ltr"><br>Correction to: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer. <a href="https://dx.doi.org/10.1038/s41467-019-13105-5" target="_blank">https://dx.doi.org/10.1038/s41467-019-13105-...
محفوظ في:
مواد مشابهة
-
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
حسب: Lei Nie (556344)
منشور في: (2019) -
Evaluation of Estrone Liposomes using Microfluidics for Breast Cancer Therapy
حسب: Al Bostami, Rouba D.
منشور في: (2023) -
Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis
حسب: Mukhopadhyay, Debasmita
منشور في: (2021) -
Estrogens and the risk of breast cancer: A narrative review of literature
حسب: Khayry Al-Shami (17863865)
منشور في: (2023) -
Ultrasound triggered release of Trastuzumab-conjugated immunoliposomes targeting breast cancer
حسب: Ahmed, Amal Elsadig Elamir
منشور في: (2018)